Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save significant healthcare costs by targeting the patients with most effective therapy.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.

The market for Companion diagnostics is classified into several categories based on technology, applications and end users.

Polymerase Chain Reaction (PCR) is the biggest revenue generating segment by type of technology used.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

The prominent players profiled in this report are:
Abbott Laboratories
Advanced Cell Diagnostics Inc.
Agilent Technologies, Inc.
bioMerieux and Biogenex Laboratories.

The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Companion diagnostics Market during the forecast period 2015-2020.